Arch Therapeutics, Inc./ US03939W1099 /

7/1/2022 9:32:19 PM	Chg. +0.0030	Volume	Bid-	Ask-	High	Low
0.0490USD	+6.52%	78,785 Turnover: 3,777.5940	-Bid Size: -	-Ask Size: -	0.0528	0.0430

GlobeNewswire 3/14 Arch Therapeutics Partners with Centurion Therapeutics to Expand Access to AC5® Advanced Wound Syste...

GlobeNewswire 1/6 Clinical Evaluation Finds Arch Therapeutics’ AC5® Advanced Wound System Effective in Healing Complex...

GlobeNewswire 1/4 Arch Therapeutics Announces Appointment of Guy Fish to the Board

GlobeNewswire 12/13/2021 Arch Therapeutics Granted Federal Supply Schedule and General Supply Administration Contracts for AC...

GlobeNewswire 12/1/2021 Arch Therapeutics Adds Key Opinion Leader Interview on Diabetic Foot Ulcers to the Experts in Wound ...

GlobeNewswire 11/1/2021 Arch Therapeutics Presents AC5® Advanced Wound System During Innovation Spotlight at 2021 Symposium ...

GlobeNewswire 10/25/2021 Arch Therapeutics to Present AC5 Advanced Wound System at 2021 Symposium on Advanced Wound Care (SAW...

GlobeNewswire 10/18/2021 Arch Therapeutics Launches Experts in Wound Care Program

GlobeNewswire 10/13/2021 Arch Therapeutics Provides Corporate Update

GlobeNewswire 10/6/2021 Arch Therapeutics to Present at the LD Micro Main Event

GlobeNewswire 10/4/2021 Arch Therapeutics Launches Coverage and Reimbursement Pilot

GlobeNewswire 9/30/2021 Arch Therapeutics Announces Appointment of Larry Hicks to the Board

GlobeNewswire 9/2/2021 Arch Therapeutics Partners with Lovell Government Services to Expand Distribution Capabilities

GlobeNewswire 7/12/2021 Arch Therapeutics Completes Leadership Team with Appointment of Dan Yrigoyen as Vice President of Sa...

GlobeNewswire 7/7/2021 Arch Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference, July 13 - 14, 202...

GlobeNewswire 6/2/2021 Arch Therapeutics to Present at the LD Micro Invitational XI, June 8 - 10, 2021

GlobeNewswire 5/10/2021 Arch Therapeutics’ AC5® Advanced Wound System Presents with Recognition at the 2021 Symposium on Adv...

GlobeNewswire 5/3/2021 Arch Therapeutics Appoints Michael S. Abrams its Chief Financial Officer

GlobeNewswire 4/27/2021 Arch Therapeutics to Present AC5® Advanced Wound System at 2021 Symposium on Advanced Wound Care (SA...

GlobeNewswire 4/19/2021 Arch Therapeutics Provides Corporate Update on Commercialization Efforts and Clinical Results

GlobeNewswire 3/2/2021 Arch Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference, March 9-10, 202...

GlobeNewswire 2/18/2021 Arch Therapeutics Announces Closing of $6.9 Million Private Placement

GlobeNewswire 2/12/2021 Arch Therapeutics Announces $6.9 Million Private Placement

GlobeNewswire 1/5/2021 Arch Therapeutics to Present at the H.C. Wainwright BioConnect Conference, January 11 - 14, 2021

GlobeNewswire 1/4/2021 Arch Therapeutics Announces Distribution Agreement with Buffalo Supply, Inc.